Myeloid-lineage-specific membrane protein LRRC25 suppresses immunity in solid tumor and is a potential cancer immunotherapy checkpoint target
Summary: Leucine-rich repeat containing 25 (LRRC25), a type I membrane protein, is specifically expressed in myeloid cells including neutrophils and macrophages. The anti-inflammatory role of LRRC25 was suggested in a few pathogenic models. However, its role in cancer immunity has not been interroga...
Tallennettuna:
| Päätekijät: | , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2025-05-01
|
| Sarja: | Cell Reports |
| Aiheet: | |
| Linkit: | http://www.sciencedirect.com/science/article/pii/S2211124725004024 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|